Treatment

Gout and Chronic Kidney Disease: Prevalence, Challenges, and Treatment

Gout, a prevalent inflammatory arthritis, is triggered by monosodium urate (MSU) crystal deposits in joints due to elevated serum urate (SU) levels. This causes intense pain and swelling,...
CURATED BY: Cristina Perez,
RN, MSN, FNP-C
Picture of Cristina Perez,
Cristina Perez,
RN, MSN, FNP-C
Family Nurse Practitioner, Carelon Health
Read More

Study Identifies Optimal eGFR for Dialysis Initiation in Advanced Chronic Kidney Disease

Researchers of this study aimed to determine the optimal estimated glomerular filtration rate (eGFR) for initiating dialysis in patients with...
Picture of Stephen Thomas,

Stephen Thomas,

FNP-C, MSN, RN
Nurse Practitioner, Nephrology Associates Medical Group
CURATED BY:
Stephen Thomas,
FNP-C, MSN, RN
Read More >

New Technologies Offer Hope for Patients With End-Stage Renal Disease Amidst Donor Organ Shortage

Over two million people globally suffer from end-stage renal disease (ESRD), with kidney transplants being the best treatment option. However,...
Picture of Cristina Perez,

Cristina Perez,

RN, MSN, FNP-C
Family Nurse Practitioner, Carelon Health
CURATED BY:
Cristina Perez,
RN, MSN, FNP-C
Read More >

EMPA-KIDNEY Trial Shows Empagliflozin Reduces CKD Progression and Cardio Risks

The EMPA-KIDNEY trial evaluated empagliflozin's effectiveness in patients with chronic kidney disease (CKD) at various stages of progression. Participants with...
Picture of Kimberly Cantillon,

Kimberly Cantillon,

MPAS, PA-C
Physician Associate, Bayer
CURATED BY:
Kimberly Cantillon,
MPAS, PA-C
Read More >

Advancing Therapies: Non-Steroidal MR Antagonists in the Spotlight for Treating Chronic Conditions

MR overactivation, implicated in various pathologies including chronic kidney disease (CKD) and type 2 diabetes mellitus, underscores the importance of...
Picture of Kimberly Cantillon,

Kimberly Cantillon,

MPAS, PA-C
Physician Associate, Bayer
CURATED BY:
Kimberly Cantillon,
MPAS, PA-C
Read More >

Finerenone Promising for Reducing CKD and Cardiovascular Risks in Type 2 Diabetes

In a double-blind trial involving 5734 patients with chronic kidney disease (CKD) and type 2 diabetes, finerenone, a selective mineralocorticoid...
Picture of Kimberly Cantillon,

Kimberly Cantillon,

MPAS, PA-C
Physician Associate, Bayer
CURATED BY:
Kimberly Cantillon,
MPAS, PA-C
Read More >

Finerenone Reduces Heart, Kidney Risks in Diabetes CKD Study

The FIDELITY analysis consolidated data from the FIDELIO-DKD and FIGARO-DKD studies, targeting patients with type 2 diabetes across different stages...
Picture of Kimberly Cantillon,

Kimberly Cantillon,

MPAS, PA-C
Physician Associate, Bayer
CURATED BY:
Kimberly Cantillon,
MPAS, PA-C
Read More >
Load More

Privacy Policy
Terms of Use

Company
Contact

Partner with Us
Ambassador Program

© 2024 Point of Care Network, LLC. All Rights Reserved.

Privacy Policy Terms of Use Company Contact Partner with Us Ambassador Program

© 2024 Point of Care Network, LLC. All Rights Reserved.

Share